Skip to search formSkip to main contentSkip to account menu

cytarabine/idarubicin/recombinant human thrombopoietin

Known as: ARA-C/IDA/rhTPO 
National Institutes of Health

Related topics

Related topics

3 relations
CytarabineIdarubicinrecombinant human thrombopoietin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
PURPOSE Recombinant human thrombopoietin (rhTPO) increases platelets, and the peak response of rhTPO is delayed and is, therefore… 
2003
2003
Importance o f P redosing o f R ecombinant H uman Thrombopoietin t o R educe C hemotherapy-Ind uced Early T hrombocytopenia
Purpose: Recombinant human thrombopoietin (rhTPO) increases platelets, and the peak response of rhTPO is delayed and is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)